
Malgorzata A. Walicka
Examiner (ID: 315)
| Most Active Art Unit | 1652 |
| Art Unit(s) | 1652 |
| Total Applications | 345 |
| Issued Applications | 187 |
| Pending Applications | 28 |
| Abandoned Applications | 130 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9691863
[patent_doc_number] => 08822457
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-09-02
[patent_title] => 'Inhibitors of bruton\'s tyrosine kinase'
[patent_app_type] => utility
[patent_app_number] => 14/024354
[patent_app_country] => US
[patent_app_date] => 2013-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27706
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14024354
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/024354 | Inhibitors of bruton's tyrosine kinase | Sep 10, 2013 | Issued |
Array
(
[id] => 10129168
[patent_doc_number] => 09162991
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-10-20
[patent_title] => 'Cinnamoyl inhibitors of transglutaminase'
[patent_app_type] => utility
[patent_app_number] => 14/015047
[patent_app_country] => US
[patent_app_date] => 2013-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 27233
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14015047
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/015047 | Cinnamoyl inhibitors of transglutaminase | Aug 29, 2013 | Issued |
Array
(
[id] => 9363927
[patent_doc_number] => 20140073799
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-13
[patent_title] => 'THIENOPYRAZOLE DERIVATIVE HAVING PDE7 INHIBITORY ACTIVITY'
[patent_app_type] => utility
[patent_app_number] => 14/013168
[patent_app_country] => US
[patent_app_date] => 2013-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 101629
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14013168
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/013168 | Thienopyrazole derivative having PDE7 inhibitory activity | Aug 28, 2013 | Issued |
Array
(
[id] => 9330098
[patent_doc_number] => 20140056880
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-27
[patent_title] => 'TRIAZOLE COMPOUNDS AS KSP INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 14/012167
[patent_app_country] => US
[patent_app_date] => 2013-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21417
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14012167
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/012167 | TRIAZOLE COMPOUNDS AS KSP INHIBITORS | Aug 27, 2013 | Abandoned |
Array
(
[id] => 9369795
[patent_doc_number] => 20140079667
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-20
[patent_title] => 'TETRAZOLONES AS INHIBITORS OF FATTY ACID SYNTHASE'
[patent_app_type] => utility
[patent_app_number] => 13/975236
[patent_app_country] => US
[patent_app_date] => 2013-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 81051
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13975236
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/975236 | Tetrazolones as inhibitors of fatty acid synthase | Aug 22, 2013 | Issued |
Array
(
[id] => 9212670
[patent_doc_number] => 20140011847
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-09
[patent_title] => 'CASPASE INHIBITORS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/968338
[patent_app_country] => US
[patent_app_date] => 2013-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 18712
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13968338
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/968338 | Caspase inhibitors and uses thereof | Aug 14, 2013 | Issued |
Array
(
[id] => 9198804
[patent_doc_number] => 20130338119
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-12-19
[patent_title] => 'Pyrrolidinone Benzenesulfonamide Derivatives as Modulators of Ion Channels'
[patent_app_type] => utility
[patent_app_number] => 13/967732
[patent_app_country] => US
[patent_app_date] => 2013-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28328
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13967732
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/967732 | Pyrrolidinone benzenesulfonamide derivatives as modulators of ion channels | Aug 14, 2013 | Issued |
| 13/984701 | ISOXAZOLINE DERIVATIVES FOR CONTROLLING INVERTEBRATE PESTS | Aug 8, 2013 | Abandoned |
Array
(
[id] => 10175973
[patent_doc_number] => 09206165
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-12-08
[patent_title] => 'Tetrazolo hydrazine derivatives and pharmaceutical composition comprising same as active ingredient for preventing or treating cancer'
[patent_app_type] => utility
[patent_app_number] => 14/419531
[patent_app_country] => US
[patent_app_date] => 2013-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7563
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14419531
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/419531 | Tetrazolo hydrazine derivatives and pharmaceutical composition comprising same as active ingredient for preventing or treating cancer | Aug 5, 2013 | Issued |
Array
(
[id] => 9295318
[patent_doc_number] => 20140038952
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-06
[patent_title] => 'Substituted Amino-Pyrimidine Derivatives'
[patent_app_type] => utility
[patent_app_number] => 13/957470
[patent_app_country] => US
[patent_app_date] => 2013-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38981
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13957470
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/957470 | Substituted amino-pyrimidine derivatives | Aug 1, 2013 | Issued |
Array
(
[id] => 12212060
[patent_doc_number] => 09908853
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-03-06
[patent_title] => 'Inhibitors of peptidyl arginine deiminase (PAD) enzymes and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 14/418570
[patent_app_country] => US
[patent_app_date] => 2013-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 11
[patent_no_of_words] => 16873
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14418570
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/418570 | Inhibitors of peptidyl arginine deiminase (PAD) enzymes and uses thereof | Jul 31, 2013 | Issued |
Array
(
[id] => 9198796
[patent_doc_number] => 20130338112
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-12-19
[patent_title] => 'COMPOUNDS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 13/956534
[patent_app_country] => US
[patent_app_date] => 2013-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 46872
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13956534
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/956534 | Compounds for the treatment of proliferative disorders | Jul 31, 2013 | Issued |
Array
(
[id] => 9175259
[patent_doc_number] => 20130317244
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-28
[patent_title] => 'ORGANIC-INORGANIC HYBRID CHIRAL SORBENT AND PROCESS FOR THE PREPARATION THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/954402
[patent_app_country] => US
[patent_app_date] => 2013-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10648
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13954402
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/954402 | Organic-inorganic hybrid chiral sorbent and process for the preparation thereof | Jul 29, 2013 | Issued |
Array
(
[id] => 11828692
[patent_doc_number] => 09725426
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-08-08
[patent_title] => 'Cystathionine-γ-lyase (CSE) inhibitors'
[patent_app_type] => utility
[patent_app_number] => 14/416596
[patent_app_country] => US
[patent_app_date] => 2013-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 34760
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14416596
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/416596 | Cystathionine-γ-lyase (CSE) inhibitors | Jul 22, 2013 | Issued |
Array
(
[id] => 13942259
[patent_doc_number] => 10206874
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-02-19
[patent_title] => Rufinamide solid dispersion
[patent_app_type] => utility
[patent_app_number] => 14/590432
[patent_app_country] => US
[patent_app_date] => 2013-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2489
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14590432
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/590432 | Rufinamide solid dispersion | Jul 17, 2013 | Issued |
Array
(
[id] => 9538593
[patent_doc_number] => 20140163240
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-12
[patent_title] => 'PROCESS FOR THE SYNTHESIS OF (+) AND (-)-1-(3,4-DICHLOROPHENYL)-3-AZABICYCLO[3.1.0]HEXANE'
[patent_app_type] => utility
[patent_app_number] => 13/945605
[patent_app_country] => US
[patent_app_date] => 2013-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3074
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13945605
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/945605 | Process for the synthesis of (+) and (−)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane | Jul 17, 2013 | Issued |
Array
(
[id] => 9813317
[patent_doc_number] => 20150025262
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-22
[patent_title] => 'BIS(ARYL)ACETAL COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 13/943232
[patent_app_country] => US
[patent_app_date] => 2013-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6535
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13943232
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/943232 | Bis(aryl)acetal compounds | Jul 15, 2013 | Issued |
Array
(
[id] => 9223586
[patent_doc_number] => 20140018361
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-16
[patent_title] => 'IRAK INHIBITORS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/939832
[patent_app_country] => US
[patent_app_date] => 2013-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34499
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13939832
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/939832 | IRAK INHIBITORS AND USES THEREOF | Jul 10, 2013 | Abandoned |
Array
(
[id] => 9222424
[patent_doc_number] => 20140017199
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-16
[patent_title] => 'MODULATORS OF PHARMACOKINETIC PROPERTIES OF THERAPEUTICS'
[patent_app_type] => utility
[patent_app_number] => 13/935117
[patent_app_country] => US
[patent_app_date] => 2013-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 121670
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13935117
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/935117 | MODULATORS OF PHARMACOKINETIC PROPERTIES OF THERAPEUTICS | Jul 2, 2013 | Abandoned |
Array
(
[id] => 9135606
[patent_doc_number] => 20130296321
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-07
[patent_title] => 'CRYSTALLINE FORMS AND PROCESSES FOR THE PREPARATION OF PHENYL-PYRAZOLES USEFUL AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR'
[patent_app_type] => utility
[patent_app_number] => 13/935329
[patent_app_country] => US
[patent_app_date] => 2013-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 23473
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13935329
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/935329 | Crystalline forms and processes for the preparation of phenyl-pyrazoles useful as modulators of the 5-HT2A serotonin receptor | Jul 2, 2013 | Issued |